Noxafil

Active Ingredient(s): Posaconazole
FDA Approved: * September 15, 2006
Pharm Company: * SCHERING
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Noxafil Overview

Posaconazole (trade name Noxafil, Posanol) is a triazole antifungal drug.[1][2] Contents 1 Medical uses 2 Pharmacology 2.1 Mode of action 2.2 Microbiology 3 Pharmacokinetics 4 Research 5 See also 6 References Medical uses Posaconazole is used to treat invasive aspergillosis and candidiasis and fungal infections caused by Scedosporium and Fusarium species, which may occur in immunocompromised patients. It is also used for the treatment of oropharynge...

Read more Noxafil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Posaconazole

Recent Noxafil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Posaconazole
  • Injection: 18mg/ml
  • Solution: 300mg/16.7ml (18mg/ml)
  • Suspension: 40mg/ml
  • Tablet, Delayed Release: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Noxafil: (3 results)

Sorted by National Drug Code
  • 0085-1328 Noxafil 40 mg/ml Oral Suspension by Merck Sharp & Dohme Corp.
  • 0085-4324 Noxafil 100 mg/1 Oral Tablet, Coated by Merck Sharp & Dohme Corp.
  • 0085-4331 Noxafil 18 mg/ml Intravenous Solution by Merck Sharp & Dohme Corp.

Other drugs which contain Posaconazole or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA